3'-O-TBDMS-2'-F-dA(Bz)
3'-O-TBDMS-2'-F-dA(Bz) - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.D1-102
-
SMILESF[C@@H]1[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO)O[C@H]1N(C=N2)C3=C2C(NC(C4=CC=CC=C4)=O)=NC=N3
-
Molecular FormulaC23H30FN5O4Si
-
Molecular Weight487.61
-
AppearanceWhite to off-white powder
-
PurityHPLC≥98.0%
-
Storage Condition2-8℃
Documentation
Documentation
-
Catalog No.D1-102
-
SMILESF[C@@H]1[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO)O[C@H]1N(C=N2)C3=C2C(NC(C4=CC=CC=C4)=O)=NC=N3
-
Molecular FormulaC23H30FN5O4Si
-
Molecular Weight487.61
-
AppearanceWhite to off-white powder
-
PurityHPLC≥98.0%
-
Storage Condition2-8℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
